Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous Ultrasound in Digital Fibrokeratomas: Series of 4 Cases.

Actas dermo-sifiliograficas·2025
Same author

Sustained Efficacy of a Short Course of Upadacitinib in Atopic Dermatitis.

Actas dermo-sifiliograficas·2025
Same author

[Translated article] Ultrasound Features of Primary Cutaneous Marginal Zone B-Cell Lymphoma.

Actas dermo-sifiliograficas·2025
Same author

Ultrasound Features of Primary Cutaneous Marginal Zone B-Cell Lymphoma.

Actas dermo-sifiliograficas·2025
Same author

[Translated article] What Wrinkles Actually Hide.

Actas dermo-sifiliograficas·2024
Same author

[Translated article] Survey on the Management of Dysplastic Nevus by Dermatologists in the Center-Spain Section of the Spanish Academy of Dermatology and Venereology (AEDV).

Actas dermo-sifiliograficas·2023
Same journal

Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanoma.

Clinical and experimental dermatology·2026
Same journal

Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort.

Clinical and experimental dermatology·2026
Same journal

A second case of recessive mosaicism in ABCA12 causing a congenital unilateral epidermal nevus.

Clinical and experimental dermatology·2026
Same journal

Dermatopathology.

Clinical and experimental dermatology·2026
Same journal

Persistent Bilateral Palmar Hyperkeratotic Papules in an Adolescent Male.

Clinical and experimental dermatology·2026
Same journal

Shuddering Attacks in an Infant Treated with Atenolol for Infantile Hemangioma: A Previously Unreported Adverse Effect.

Clinical and experimental dermatology·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Mondor's disease.

H Alvarez-Garrido1, A A Garrido-Ríos, C Sanz-Muñoz

  • 1Department of Dermatology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain. helenaalvarezgarrido@hotmail.com

Clinical and Experimental Dermatology
|July 7, 2009
PubMed
Summary
This summary is machine-generated.

Mondor's disease is a rare thrombophlebitis of subcutaneous veins. Recent diagnostic methods help differentiate affected vessels, aiding in understanding and managing this condition.

More Related Videos

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

  • Vascular Medicine
  • Dermatopathology

Background:

  • Mondor's disease (MD) is a rare thrombophlebitis affecting subcutaneous veins.
  • It typically presents as a cord-like induration on the thoracoabdominal wall, but can occur in other regions.
  • The pathogenesis remains unclear due to difficulties in distinguishing veins from lymphatic vessels.

Purpose of the Study:

  • To highlight the diagnostic challenges and recent advancements in understanding Mondor's disease.
  • To emphasize the importance of differentiating venous from lymphatic vessels in MD diagnosis.
  • To recommend investigations for associated systemic conditions.

Main Methods:

  • Review of clinical features and diagnostic approaches for Mondor's disease.
  • Discussion of immunohistochemical staining (CD31 and D240) for differentiating small veins and lymphatic vessels.
  • Consideration of laboratory studies to rule out systemic disorders.

Main Results:

  • Immunohistochemical staining with CD31 and D240 is effective in distinguishing small veins from lymphatic vessels.
  • This technique is valuable for diagnosing MD and other vascular/lymphatic conditions.
  • MD is associated with systemic diseases like breast cancer and hypercoagulability.

Conclusions:

  • Accurate diagnosis of MD is enhanced by differentiating between venous and lymphatic vessels.
  • Laboratory workup is recommended to exclude underlying systemic diseases.
  • Treatment for MD is generally conservative, reserved for symptomatic or recurrent cases.